한글목차

신생아 스크리닝 세계 시장은 2024년에는 8억 5,415만 달러로 평가되었고, 2030년까지는 13억 4,511만 달러에 이를 것으로 예측되고, 예측 기간 중 CAGR은 7.86%를 나타낼 전망입니다.

이 시장에는 신생아의 유전적, 대사적, 선천성 질환을, 일반적으로 출생 후 며칠 이내에 조기 발견 및 진단하는 것이 포함됩니다. 선천성 장애가 전 세계적으로 유아 이환율과 사망률에서 상당한 비중을 차지함에 따라 신생아 검진은 공공 의료 시스템의 중요한 구성 요소가 되었습니다. 정부 이니셔티브 증가, 선별 기술 발전, 그리고 질병 조기 발견에 대한 인식 상승이 보급률을 크게 높였습니다. 질병의 유병률 증가는 민간 검사 이니셔티브, 건강 관리 지출 증가, 스크리닝 관행을 표준화하는 세계 협력 체제에 의해 지원되며 시장 성장을 유지할 것으로 예측됩니다.

주요 시장 성장 촉진요인

기술 진보

주요 시장 과제

교육과 인식

주요 시장 동향

민간검사 증가

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 신생아 스크리닝 시장에 대한 COVID-19의 영향

제5장 고객의 목소리

제6장 세계의 신생아 스크리닝 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 기술별(탠덤 질량 분석법, 펄스 옥시메트리, 효소 검정, DNA 검정, 기타 기술)
  • 검사 유형별(건조 혈흔 검사, 청력 검사, 심각한 선천성 심장 질환(CCHD), 기타 검사 유형)
  • 최종 사용자별(병원, 진단센터, 기타 최종 사용자)별
  • 지역별
  • 기업별(2024년)
• 시장 맵

제7장 아시아태평양 신생아 스크리닝 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제8장 유럽 신생아 스크리닝 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제9장 북미 신생아 스크리닝 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제10장 남미의 신생아 스크리닝 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제11장 중동 및 아프리카의 신생아 스크리닝 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제12장 시장 역학

• 성장 촉진요인
• 과제

제13장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제14장 세계 신생아 스크리닝 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제16장 PESTEL 분석

제17장 경쟁 구도

• Bio-Rad Laboratories Inc.
• GE Healthcare
• Masimo Corporation
• Medtronic Inc.
• Natus Medical Incorporated
• PerkinElmer Inc.
• Trivitron Healthcare
• ZenTech SA
• Demant A/S
• Hill-Rom Holdings Inc.

제18장 전략적 제안

제19장 기업 소개와 면책사항

영문목차

The Global Newborn Screening Market was valued at USD 854.15 million in 2024 and is projected to reach USD 1345.11 million by 2030, growing at a CAGR of 7.86% during the forecast period. This market encompasses the early detection and diagnosis of genetic, metabolic, and congenital conditions in newborns, typically within the first days after birth. As congenital disorders continue to account for a significant share of infant morbidity and mortality globally, newborn screening has become a vital component of public healthcare systems. Increased government initiatives, advancements in screening technologies, and rising awareness regarding early disease detection have significantly boosted adoption rates. Countries are expanding their newborn screening panels to include a broader array of conditions, while innovations such as next-generation sequencing and tandem mass spectrometry have improved diagnostic accuracy and efficiency. The growing prevalence of congenital conditions, particularly in developing regions, is expected to sustain market growth, supported by private testing initiatives, increased healthcare spending, and global collaborations to standardize screening practices.

Key Market Drivers

Advancements in Technology

Technological innovations have transformed newborn screening, enabling earlier and more precise detection of a wide array of conditions. Next-Generation Sequencing (NGS) facilitates simultaneous analysis of multiple genes, significantly expanding screening capabilities. It has become instrumental in identifying rare and complex genetic conditions with high accuracy. Similarly, Tandem Mass Spectrometry (MS/MS) has revolutionized metabolic screening by allowing multiple analytes to be tested from a single sample, enabling detection of amino acid and fatty acid disorders efficiently. Multiplex assays and enhanced dried blood spot (DBS) technologies have also contributed to the broader and faster adoption of screening for lysosomal storage and immunodeficiency disorders. These technological advancements have reduced false positives, improved patient outcomes, and lowered healthcare costs through early interventions.

Key Market Challenges

Education and Awareness

Despite technological progress, limited public and professional awareness about the significance of newborn screening remains a substantial barrier. Many parents may lack understanding of the benefits and procedures involved, leading to hesitation or refusal of screening. Inconsistent training and knowledge dissemination among healthcare professionals can further impair effective communication with families. Cultural and language differences, especially in diverse or low-resource regions, exacerbate the issue, hindering outreach and engagement. Additionally, varying policies and resource availability across countries contribute to disparities in screening coverage and effectiveness. Efforts to improve education, standardize procedures, and address misinformation are crucial to increasing participation and acceptance globally.

Key Market Trends

Rise in Private Testing

There is a growing trend toward private newborn screening services, as parents increasingly seek broader testing panels than those offered by public health programs. Personalized medicine, rapid result delivery, and advanced technologies are driving demand for private services. These centers offer greater autonomy and confidentiality, along with supplemental services like genetic counseling and family health planning. In regions with limited or inconsistent public programs, private testing ensures continued access to comprehensive screening. Additionally, private providers often serve mobile populations seeking continuity of care across borders. As awareness grows and disposable incomes rise, private newborn screening is expected to gain further traction, especially in urban and high-income segments.

Key Market Players

• Bio-Rad Laboratories Inc.
• GE Healthcare
• Masimo Corporation
• Medtronic Inc.
• Natus Medical Incorporated
• PerkinElmer Inc.
• Trivitron Healthcare
• ZenTech SA
• Demant A/S
• Hill-Rom Holdings Inc.

Report Scope

In this report, the Global Newborn Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Newborn Screening Market, By Technology:

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme Based Assays
• DNA Assays
• Other Technologies

Newborn Screening Market, By Test Type:

• Dried Blood Spot
• Hearing Screening
• Critical Congenital Heart Defect (CCHD)
• Other Test Types

Newborn Screening Market, By End User:

• Hospitals
• Diagnostic Centers
• Other End Users

Newborn Screening Market, By Region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Newborn Screening Market.

Available Customizations

Global Newborn Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Newborn Screening Market

5. Voice of Customer

6. Global Newborn Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Other Technologies)
  • 6.2.2. By Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), and Other Test Types)
  • 6.2.3. By End User (Hospitals, Diagnostic Centers, and Other End Users),
  • 6.2.4. By Region
  • 6.2.5. By Company (2024)
• 6.3. Market Map

7. Asia Pacific Newborn Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Test Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Asia Pacific: Country Analysis
  • 7.3.1. China Newborn Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By End User
  • 7.3.2. India Newborn Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By End User
  • 7.3.3. Australia Newborn Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Japan Newborn Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By End User
  • 7.3.5. South Korea Newborn Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By End User

8. Europe Newborn Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Test Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Newborn Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By End User
  • 8.3.2. Germany Newborn Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Spain Newborn Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By End User
  • 8.3.4. Italy Newborn Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By End User
  • 8.3.5. United Kingdom Newborn Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By End User

9. North America Newborn Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Test Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. North America: Country Analysis
  • 9.3.1. United States Newborn Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Mexico Newborn Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Canada Newborn Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By End User

10. South America Newborn Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Test Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Newborn Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Argentina Newborn Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Colombia Newborn Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By End User

11. Middle East and Africa Newborn Screening Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Technology
  • 11.2.2. By Test Type
  • 11.2.3. By End User
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Newborn Screening Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Technology
      • 11.3.1.2.2. By Test Type
      • 11.3.1.2.3. By End User
  • 11.3.2. Saudi Arabia Newborn Screening Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Technology
      • 11.3.2.2.2. By Test Type
      • 11.3.2.2.3. By End User
  • 11.3.3. UAE Newborn Screening Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Technology
      • 11.3.3.2.2. By Test Type
      • 11.3.3.2.3. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Product Launches
• 13.3. Mergers & Acquisitions

14. Global Newborn Screening Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

• 17.1. Bio-Rad Laboratories Inc.
  • 17.1.1. Business Overview
  • 17.1.2. Company Snapshot
  • 17.1.3. Products & Services
  • 17.1.4. Financials (As Reported)
  • 17.1.5. Recent Developments
  • 17.1.6. Key Personnel Details
  • 17.1.7. SWOT Analysis
• 17.2. GE Healthcare
• 17.3. Masimo Corporation
• 17.4. Medtronic Inc.
• 17.5. Natus Medical Incorporated
• 17.6. PerkinElmer Inc.
• 17.7. Trivitron Healthcare
• 17.8. ZenTech SA
• 17.9. Demant A/S
• 17.10. Hill-Rom Holdings Inc.

18. Strategic Recommendations

19. About Us & Disclaimer